Quarterly Call Option Transactions in Acadia Pharmaceuticals Inc (ACAD)
This table provides information about the institutional ownership of Acadia Pharmaceuticals Inc (ACAD) during . The information is specifically focused on institutions that hold call options of ACADIA PHARMACEUTICALS INC.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 126,100 | 229,100 | 355,200 | 87,400 | 602,100 | 689,500 | -334,300 | |
| Q4 2021 | 1,035,600 | 1,271,700 | 2,307,300 | 39,000 | 27,300 | 66,300 | 2,241,000 | |
| Q1 2022 | 10,600 | 77,100 | 87,700 | 590,200 | 1,619,500 | 2,209,700 | -2,122,000 | |
| Q2 2022 | 63,800 | 399,400 | 463,200 | 173,400 | 9,000 | 182,400 | 280,800 | |
| Q3 2022 | 17,000 | 31,500 | 48,500 | 758,300 | 0 | 758,300 | -709,800 | |
| Q4 2022 | 5,100 | 110,600 | 115,700 | 58,900 | 0 | 58,900 | 56,800 | |
| Q1 2023 | 49,600 | 41,000 | 90,600 | 86,200 | 0 | 86,200 | 4,400 | |
| Q2 2023 | 6,700 | 27,500 | 34,200 | 6,500 | 0 | 6,500 | 27,700 | |
| Q3 2023 | 269,200 | 197,100 | 466,300 | — | 466,300 | |||
| Q4 2023 | 8,300 | 209,500 | 217,800 | 172,300 | 0 | 172,300 | 45,500 | |
| Q1 2024 | 729,300 | 779,400 | 1,508,700 | 5,200 | 0 | 5,200 | 1,503,500 | |
| Q2 2024 | 40,500 | 289,800 | 330,300 | 609,000 | 0 | 609,000 | -278,700 | |
| Q3 2024 | 504,700 | 15,700 | 520,400 | 9,700 | 0 | 9,700 | 510,700 | |